MP17: Prostate Cancer: Markers

Poster Session Moderator(s)

• 

  Ketan Badani

  Icahn School of Medicine at Mount Sinai Hospital
• AO

  Ana Ojeda, MD,Phd
• MR

  Miguel Rodrigo-Aliaga, MD,PhD

  Urologist. Head of Department of Urology

Presentations:

• 1:00 PM – 3:00 PM CST

  MP17-01: Differential Transcriptomic Indicators of Potential Therapeutic Response to Targeted Therapy for AJCC IIC+ Localized Prostate Cancer with Decipher ≥0.95
  

  Poster Presenter: Eric V. Li, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP17-02: Association between the Decipher genomic classifier and prostate cancer outcome in a large-scale real-world dataset
  

  Poster Presenter: Michael Leapman, MD – Yale University Department of Urology
• 1:00 PM – 3:00 PM CST

  MP17-03: The 17-gene Genomic Prostate Score^® assay is prognostic for biochemical failure in men with localized prostate cancer after radiation therapy at a community cancer center
  

  Poster Presenter: Daniel Canter
• 1:00 PM – 3:00 PM CST

  MP17-04: Impact of Tissue-Based Genomic Testing on Payments for Prostate Cancer Care
  

  Poster Presenter: Benjamin J. Croll, MD (he/him/his) – Emory University School of Medicine
• 1:00 PM – 3:00 PM CST

  MP17-05: Association of Urology Practice Implementation of Multiparametric MRI and Genomic Testing on Treatment Rates in Men With Newly diagnosed Prostate Cancer
  

  Poster Presenter: Kassem Faraj, MD
• 1:00 PM – 3:00 PM CST

  MP17-06: Validation of EAU Risk groups for biochemical recurrence after radiotherapy and radical prostatectomy for prediction of prostate cancer mortality.
  

  Poster Presenter: Ugo G. Falagario, MD – University of Foggia
• 1:00 PM – 3:00 PM CST

  MP17-07: Validation of MiCheck Prostate for significant prostate cancer in an Australian population
  

  Poster Presenter: David Antony Gillatt, MD – Dr David Antony Gillatt
• 1:00 PM – 3:00 PM CST

  MP17-08: Clinical validation of a novel six-gene risk-stratification signature to support treatment decisions for men diagnosed with prostate cancer
  
  

  Poster Presenter: Agnieszka Krzyzanowska, PHD – Lund University
• 1:00 PM – 3:00 PM CST

  MP17-09: Development of a Longitudinal Prostate Cancer Transcriptomic and Real-World Clinical Data Linkage
  

  Poster Presenter: Michael Leapman, MD – Yale University Department of Urology
• 1:00 PM – 3:00 PM CST

  MP17-10: Development and Utilization of an At Home Urine Exosome Biomarker Collection Test Kit to Support Urologic Telehealth
  

  Poster Presenter: Ali Kasraeian, MD, FACS
• 1:00 PM – 3:00 PM CST

  MP17-11: Refinement and External Validation of a Novel Multiplex Urine Test for High-Grade Prostate Cancer
  

  Poster Presenter: Nathan L. Samora, MD – UC Davis Health
• 1:00 PM – 3:00 PM CST

  MP17-12: Immune score of tumor-infiltrating CD8+ and FoxP3+ lymphocytes as a novel prognostic biomarker in high-risk localized prostate cancer who underwent radical prostatectomy
  

  Poster Presenter: Hiromi Sato, MD
• 1:00 PM – 3:00 PM CST

  MP17-13: Prognostic value of pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
  

  Poster Presenter: Zhipeng Wang
• 1:00 PM – 3:00 PM CST

  MP17-15: Infrared-(IR)-Imaging Classifies Prostate Cancer Label-free: a Prospective IR-ProSPECT-Study Shows Potential for Clinical Application and Research
  

  Poster Presenter: Henning Bahlburg, MD (he/him/his) – Marienhospital Herne, Urological Clinic
• 1:00 PM – 3:00 PM CST

  MP17-16: Comparing Intraductal Carcinoma of the Prostate to Grade and Stage: a Copy Number Alteration Characterization Study
  

  Poster Presenter: Helen Pantazopoulos, BS, MSC
• 1:00 PM – 3:00 PM CST

  MP17-17: Germline mutational carrier frequency analysis in Korean metastatic prostate cancer : a large cohort study
  

  Poster Presenter: Jin Noh
• 1:00 PM – 3:00 PM CST

  MP17-18: Prostate Cancer Genetic Alterations in Hispanic Men
  

  Poster Presenter: Camilo Arenas Gallo, MD (he/him/his) – Case Western Reserve University
• 1:00 PM – 3:00 PM CST

  MP17-19: Gene Mutations Among Prostate Cancer Patients with a Smoking History
  

  Podium Presenter: Ahmed Elshafei
• 1:00 PM – 3:00 PM CST

  MP17-20: Epigenetic regulator KMT2C mutation detected by liquid biopsy is associated with worse survival in prostate cancer patients
  

  Poster Presenter: Xingming Zhang